Doherty has over 25 years of professional experience in product development, process development, clinical production, and the commercial manufacture of medical devices, biologics, and pharmaceuticals. Prior to joining the Wyss, he was developing a programmable polymer melanoma vaccine at InCytu Inc. He has also served as Director of Manufacturing and Process Development for a variety of biotechnology companies focusing on a wide range of products, including cell-derived human skin equivalents, iontophorectic drug delivery, surgical sealants, and biohybrid artificial organs. His research interests and prior experience include: tissue engineering and drug delivery, cell culture, degradable polymeric devices, and project management. Doherty received his B.S. in Biological-Chemical Technology and his M.S. in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University.